vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and LEGALZOOM.COM, INC. (LZ). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $190.3M, roughly 1.2× LEGALZOOM.COM, INC.). LEGALZOOM.COM, INC. runs the higher net margin — 3.2% vs -35.0%, a 38.2% gap on every dollar of revenue. On growth, LEGALZOOM.COM, INC. posted the faster year-over-year revenue change (17.7% vs -23.6%). LEGALZOOM.COM, INC. produced more free cash flow last quarter ($28.0M vs $16.1M). Over the past eight quarters, LEGALZOOM.COM, INC.'s revenue compounded faster (4.5% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

LegalZoom.com, Inc. is an American online legal technology and services company launched in 2001. It provides online legal services using an independent network of attorneys and the LegalZoom-owned law firm, LegalZoom Legal Services, as well as self-service technology and care specialists. Services include wills and living trusts, business compliance such as licenses and permits, copyright registrations, and trademark applications. The company also offers attorney referrals and registered age...

CCRN vs LZ — Head-to-Head

Bigger by revenue
CCRN
CCRN
1.2× larger
CCRN
$236.8M
$190.3M
LZ
Growing faster (revenue YoY)
LZ
LZ
+41.3% gap
LZ
17.7%
-23.6%
CCRN
Higher net margin
LZ
LZ
38.2% more per $
LZ
3.2%
-35.0%
CCRN
More free cash flow
LZ
LZ
$11.9M more FCF
LZ
$28.0M
$16.1M
CCRN
Faster 2-yr revenue CAGR
LZ
LZ
Annualised
LZ
4.5%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
LZ
LZ
Revenue
$236.8M
$190.3M
Net Profit
$-82.9M
$6.1M
Gross Margin
67.6%
Operating Margin
-30.2%
6.6%
Net Margin
-35.0%
3.2%
Revenue YoY
-23.6%
17.7%
Net Profit YoY
-2109.7%
-52.9%
EPS (diluted)
$-2.56
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
LZ
LZ
Q4 25
$236.8M
$190.3M
Q3 25
$250.1M
$190.2M
Q2 25
$274.1M
$192.5M
Q1 25
$293.4M
$183.1M
Q4 24
$309.9M
$161.7M
Q3 24
$315.1M
$168.6M
Q2 24
$339.8M
$177.4M
Q1 24
$379.2M
$174.2M
Net Profit
CCRN
CCRN
LZ
LZ
Q4 25
$-82.9M
$6.1M
Q3 25
$-4.8M
$4.5M
Q2 25
$-6.7M
$-266.0K
Q1 25
$-490.0K
$5.1M
Q4 24
$-3.8M
$12.9M
Q3 24
$2.6M
$11.1M
Q2 24
$-16.1M
$1.3M
Q1 24
$2.7M
$4.7M
Gross Margin
CCRN
CCRN
LZ
LZ
Q4 25
67.6%
Q3 25
20.4%
67.3%
Q2 25
20.4%
65.0%
Q1 25
20.0%
63.7%
Q4 24
67.0%
Q3 24
20.4%
67.5%
Q2 24
20.8%
64.1%
Q1 24
20.4%
60.7%
Operating Margin
CCRN
CCRN
LZ
LZ
Q4 25
-30.2%
6.6%
Q3 25
-2.4%
3.4%
Q2 25
-2.1%
-1.6%
Q1 25
-0.3%
4.9%
Q4 24
-1.1%
8.1%
Q3 24
0.9%
9.6%
Q2 24
-5.7%
0.6%
Q1 24
0.8%
2.9%
Net Margin
CCRN
CCRN
LZ
LZ
Q4 25
-35.0%
3.2%
Q3 25
-1.9%
2.4%
Q2 25
-2.4%
-0.1%
Q1 25
-0.2%
2.8%
Q4 24
-1.2%
7.9%
Q3 24
0.8%
6.6%
Q2 24
-4.7%
0.7%
Q1 24
0.7%
2.7%
EPS (diluted)
CCRN
CCRN
LZ
LZ
Q4 25
$-2.56
$0.03
Q3 25
$-0.15
$0.02
Q2 25
$-0.20
$0.00
Q1 25
$-0.02
$0.03
Q4 24
$-0.13
$0.07
Q3 24
$0.08
$0.06
Q2 24
$-0.47
$0.01
Q1 24
$0.08
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
LZ
LZ
Cash + ST InvestmentsLiquidity on hand
$108.7M
$203.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$171.9M
Total Assets
$449.0M
$511.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
LZ
LZ
Q4 25
$108.7M
$203.1M
Q3 25
$99.1M
$237.2M
Q2 25
$81.2M
$217.0M
Q1 25
$80.7M
$210.0M
Q4 24
$81.6M
$142.1M
Q3 24
$64.0M
$112.5M
Q2 24
$69.6M
$118.8M
Q1 24
$5.2M
$228.1M
Stockholders' Equity
CCRN
CCRN
LZ
LZ
Q4 25
$322.8M
$171.9M
Q3 25
$408.1M
$201.9M
Q2 25
$412.2M
$194.1M
Q1 25
$418.2M
$187.2M
Q4 24
$419.0M
$93.3M
Q3 24
$424.7M
$60.1M
Q2 24
$433.3M
$60.8M
Q1 24
$462.4M
$167.9M
Total Assets
CCRN
CCRN
LZ
LZ
Q4 25
$449.0M
$511.5M
Q3 25
$538.2M
$551.1M
Q2 25
$553.8M
$543.0M
Q1 25
$576.2M
$532.7M
Q4 24
$589.3M
$373.9M
Q3 24
$597.4M
$348.8M
Q2 24
$602.9M
$359.5M
Q1 24
$648.4M
$459.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
LZ
LZ
Operating Cash FlowLast quarter
$18.2M
$34.1M
Free Cash FlowOCF − Capex
$16.1M
$28.0M
FCF MarginFCF / Revenue
6.8%
14.7%
Capex IntensityCapex / Revenue
0.9%
3.2%
Cash ConversionOCF / Net Profit
5.63×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$147.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
LZ
LZ
Q4 25
$18.2M
$34.1M
Q3 25
$20.1M
$54.2M
Q2 25
$4.2M
$39.1M
Q1 25
$5.7M
$50.7M
Q4 24
$24.2M
$42.6M
Q3 24
$7.5M
$31.6M
Q2 24
$82.4M
$27.2M
Q1 24
$6.0M
$34.2M
Free Cash Flow
CCRN
CCRN
LZ
LZ
Q4 25
$16.1M
$28.0M
Q3 25
$17.9M
$47.0M
Q2 25
$2.3M
$31.6M
Q1 25
$3.8M
$41.3M
Q4 24
$21.7M
$35.9M
Q3 24
$6.3M
$22.0M
Q2 24
$79.6M
$17.4M
Q1 24
$3.8M
$24.7M
FCF Margin
CCRN
CCRN
LZ
LZ
Q4 25
6.8%
14.7%
Q3 25
7.2%
24.7%
Q2 25
0.8%
16.4%
Q1 25
1.3%
22.6%
Q4 24
7.0%
22.2%
Q3 24
2.0%
13.0%
Q2 24
23.4%
9.8%
Q1 24
1.0%
14.2%
Capex Intensity
CCRN
CCRN
LZ
LZ
Q4 25
0.9%
3.2%
Q3 25
0.9%
3.8%
Q2 25
0.7%
3.9%
Q1 25
0.6%
5.1%
Q4 24
0.8%
4.1%
Q3 24
0.4%
5.7%
Q2 24
0.8%
5.6%
Q1 24
0.6%
5.4%
Cash Conversion
CCRN
CCRN
LZ
LZ
Q4 25
5.63×
Q3 25
12.03×
Q2 25
Q1 25
9.89×
Q4 24
3.31×
Q3 24
2.92×
2.86×
Q2 24
20.74×
Q1 24
2.23×
7.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

LZ
LZ

Segment breakdown not available.

Related Comparisons